Prins MH - Search Results

1

Empirical evidence of design-related bias in studies of diagnostic tests.

Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM. Lijmer JG, et al. Among authors: prins mh. JAMA. 1999 Sep 15;282(11):1061-6. doi: 10.1001/jama.282.11.1061. JAMA. 1999. PMID: 10493205

2

Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study.

Ten Wolde M, Hagen PJ, Macgillavry MR, Pollen IJ, Mairuhu AT, Koopman MM, Prins MH, Hoekstra OS, Brandjes DP, Postmus PE, Büller HR; Advances in New Technologies Evaluating the Localization of Pulmonary Embolism Study Group. Ten Wolde M, et al. Among authors: prins mh. J Thromb Haemost. 2004 Jul;2(7):1110-7. doi: 10.1111/j.1538-7836.2004.00769.x. J Thromb Haemost. 2004. PMID: 15219194 Free article.

3

Acute pulmonary embolism: impact of selection bias in prospective diagnostic studies. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism.

Hartmann IJ, Prins MH, Büller HR, Banga JD; ANTELOPE study group. Hartmann IJ, et al. Among authors: prins mh. Thromb Haemost. 2001 Apr;85(4):604-8. Thromb Haemost. 2001. PMID: 11341492

4

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

van der Heijden JF, Hutten BA, Büller HR, Prins MH. van der Heijden JF, et al. Among authors: prins mh. Cochrane Database Syst Rev. 2002;(1):CD002001. doi: 10.1002/14651858.CD002001. Cochrane Database Syst Rev. 2002. PMID: 11869618 Updated. Review.

5

For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same?

van der Heijden JF, Prins MH, Büller HR. van der Heijden JF, et al. Among authors: prins mh. Thromb Res. 2000 Oct 15;100(2):V121-30. doi: 10.1016/s0049-3848(00)00272-3. Thromb Res. 2000. PMID: 11053625

6

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

van Der Heijden JF, Hutten BA, Büller HR, Prins MH. van Der Heijden JF, et al. Among authors: prins mh. Cochrane Database Syst Rev. 2000;(4):CD002001. doi: 10.1002/14651858.CD002001. Cochrane Database Syst Rev. 2000. PMID: 11034739 Updated. Review.

7

Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, Mak R, Keyzers KC, Büller HR. Cromheecke ME, et al. Among authors: prins mh. Lancet. 2000 Jul 8;356(9224):97-102. doi: 10.1016/S0140-6736(00)02470-3. Lancet. 2000. PMID: 10963245 Clinical Trial.

8

Triage of patients for short term observation after elective coronary angioplasty.

Koch KT, Piek JJ, Prins MH, de Winter RJ, Mulder K, Lie KI, Tijssen JG. Koch KT, et al. Among authors: prins mh. Heart. 2000 May;83(5):557-63. doi: 10.1136/heart.83.5.557. Heart. 2000. PMID: 10768908 Free PMC article.

9

Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists.

Hutten BA, Prins MH, Redekop WK, Tijssen JG, Heisterkamp SH, Büller HR. Hutten BA, et al. Among authors: prins mh. Thromb Haemost. 1999 Oct;82(4):1260-3. Thromb Haemost. 1999. PMID: 10544910 Clinical Trial.

10

Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease.

Wittekoek ME, de Groot E, Prins MH, Trip MD, Büller HR, Kastelein JJ. Wittekoek ME, et al. Among authors: prins mh. Atherosclerosis. 1999 Oct;146(2):271-9. doi: 10.1016/s0021-9150(99)00147-1. Atherosclerosis. 1999. PMID: 10532683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results